Sentences with phrase «share growth rate on»

Not exact matches

«While we agree that share repurchase is likely more accretive to 2018 EPS, [Express Scripts»] more pressing challenge is business growth, making deals like eviCore a necessity,» said RBC's Hill, who has a sector perform rating on Express Scripts shares.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.
This is normally accomplished by taking the dividends earned on each share and dividing it by the share's current market value, and then adding the share's dividend growth rate to the equation to equal the rate or return required.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations; pricing actions; and other factors.
Written by NCEO founder Corey Rosen, this issue brief discusses as of mid-2016 the extent and growth of employee ownership; survey data on ESOPs and corporate governance as well as ESOPs and executive compensation; research on the effect of ESOPs on corporate performance; the 2012 shared capitalism study of Great Place to Work applicants; data on employee ownership and employee financial well - being; the NCEO's analysis of data on ESOPs and default rates; trends in broad - based equity compensation plans; equity compensation and corporate performance; the impact of ESOPs and other broad - based plans on unemployment; legislative and regulatory issues for employee ownership; and international developments in broad - based plans.
The 18.1 % growth expected this year for US display advertising is down somewhat from more robust rates of increase in 2011 and 2012, but eMarketer continues to be bullish on the prospects for digital display advertising — especially at social media properties like Facebook and Twitter, as well as at Google, which has dramatically increased its overall share of the display market in recent years.
If the stock price remains stable I will not sell the entire position due to the attractive dividend growth rate but instead prune it back by selling some shares to capitalize on the gains and reinvest the proceeds to help with income and diversification.
However, given the recent deterioration in the growth outlook in Europe and several Emerging Market countries, our view is that Canada's larger share of exports will likely have a relatively larger «negative» impact on Canadian growth, and by inference cause the BoC to be more cautious raising policy rates than the Fed.
Split by applications, this report focuses on sales, market share and growth rate of Cryptocurrency in each application: Transaction, Investment, Other
In a report published Tuesday, Pacific Crest Securities analyst Brad Erickson reiterated an Overweight rating on shares of Ambarella Inc (NASDAQ: AMBA) with a price target raised to $ 96 from a previous $ 78 given a growth and margin expansion trajectory through 2018.
Growth Investing — An investing strategy that focuses on stocks that are growing at a higher rate, without regard to price per share.
In addition, the quality of management also manifests itself in the numbers: in ROE (absolute and relative to competitors), return on total capital, growth rate, industry position, trend of market share, and profit margins» Leon Cooperman
The 2017 budget was to ensure confidence in the economy — Ken Ofori - Atta 10:52 The cedi remains relatively stable against he major currencies — Ken Ofori - Atta 10:51 Interest rate in 2017 continue to decline — Ken Ofori - Atta 10:50 Inflation continue to decline in 2017 — Ken Ofori - Atta 10:48 We have returned to a robust growth after 2016 recorded the worst growth in three decades — Ken Ofori - Atta 10:47 The call to relieve our country and people from a wretched existence is urgent — Ken Ofori - Atta 10:45 The should not simply be a statement to share the national cake between different groups but it should capture how a nation comes together to meet the challenges of our time — Ken Ofori - Atta 10:45 We plan on providing opportunities as many Ghanaians as possible.
This report focuses on the top players in global market, like Match PlentyofFish OkCupid Zoosk eHarmony JiaYuan BaiHe ZheNai YouYuan NetEase Table of Content Global Online Dating Services Market Size, Status and Forecast 2022 1 Industry Overview of Online Dating Services 1.1 Online Dating Services Market Overview 1.1.1 Online Dating Services Product Scope 1.1.2 Market Status and Outlook 1.2 Global Online Dating Services Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Online Dating Services Market by End Users / Application 1.3.1 for all 1.3.2 only for LGBT 2 Global Online Dating Services Competition Analysis by Players 2.1 Online Dating Services Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product / Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Obtain Report Details @ http://www.qyresearchreports.com/report/global-online-dating-services-market-size-status-and-forecast-2022.htm 3 Company (Top Players) Profiles 3.1 Match 3.1.1 Company Profile 3.1.2 Main Business / Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Online Dating Services Revenue (Value)(2012 - 2017) 3.1.5 Recent Developments 3.2 PlentyofFish 3.2.1 Company Profile 3.2.2 Main Business / Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Online Dating Services Revenue (Value)(2012 - 2017) 3.2.5 Recent Developments 3.3 OkCupid 3.3.1 Company Profile 3.3.2 Main Business / Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Online Dating Services Revenue (Value)(2012 - 2017) 3.3.5 Recent Developments 3.4 Zoosk 3.4.1 Company Profile 3.4.2 Main Business / Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Online Dating Services Revenue (Value)(2012 - 2017) 3.4.5 Recent Developments 3.5 eHarmony 3.5.1 Company Profile 3.5.2 Main Business / Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Online Dating Services Revenue (Value)(2012 - 2017) 3.5.5 Recent Developments List of Tables and Figures Figure Online Dating Services Product Scope Figure Global Online Dating Services Market Size (Million USD)(2012 - 2017) Table Global Online Dating Services Market Size (Million USD) and Growth Rate by Regions (2012 - 2017) Figure Global Online Dating Services Market Share by Regions in 2016 Figure United States Online Dating Services Market Size (Million USD) and Growth Rate by Regions (2012 - 2017) Figure EU Online Dating Services Market Size (Million USD) and Growth Rate by Regions (2012 - 2017) Figure Japan Online Dating Services Market Size (Million USD) and Growth Rate by Regions (2012 - 2017) Figure OkCupid Online Dating Services Business Revenue Market Share in 2016 Table Zoosk Basic Information List Table Online Dating Services Business Revenue (Million USD) of Zoosk (2012 - 2017) Figure Zoosk Online Dating Services Business Revenue Market Share in 2016 Table eHarmony Basic Information List Table Online Dating Services Business Revenue (Million USD) of eHarmony (2012 - 2017) Figure eHarmony Online Dating Services Business Revenue Market Share in 2016 About Us QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China.
In view of the large share of state budgets devoted to public education and the cost increases expected in the future, it is appropriate to ask how state policymakers might reduce the rate of growth of local and state spending on education.
The strategy for Nissan this year would to attempt to increase market share from the current rate at 1.5 % to 5 % in the Indian passenger car segment, which saw the sale of over 26 lakh cars in the fiscal year 14 - 15, when the segment registered a year - on - year growth of 3.9 %.
I come up with a more conservative 9 % long - term growth rate (G) based on the increase in pro forma earnings per share from 2006 to the low end of the projected 2007 earnings per share.
Some of these factors include above average earnings per - share growth rates, above average return on equity, excess free cash flow, low debt - to - equity ratios, and shareholder friendly management.
On the growth side, we favour firms that have increased their sales - per - share and earnings - per - share at a reasonable rate.
On the growth side, we favour firms that have increased their sales per share and earnings per share at a reasonable rate.
On the plus side, the growth rate in credit union market share is higher in New York than it is in California.
Some of these factors include above - average earnings per - share growth rates, above - average return on equity, excess - free cash flow, low debt - to - equity ratios, and shareholder - friendly management.
As with dividend growth itself, a couple of these metrics have downward trends: Return on equity (ROE) and EPS (Earnings per share) growth rates have been declining since 2012, and both are worrisome.
My addition to the Tweedy Browne commentary is that I believe investors should focus on the earnings per share growth rate of the firm during your holding period to figure out whether it makes sense.
The price - earnings ratio based on forecasted earnings for the next fiscal year is no more than one - half the projected long - term growth rate in earnings per share
Shares of 3M are trading above its historical average P / E, but this is warranted based on the company's earnings growth rate going forward.
A Score for each value stock is then assigned based on six historical variables: market cap, stock liquidity (i.e., annual trading volume / shares), asset turnover (i.e., assets / revenues), total debt to equity, cash to assets and year - over-year EBIT annual growth rate, one variable at a time.
Now that Johnson & Johnson is a $ 341 billion company, the dividend growth that continues at a rate of more than double the prevailing inflation rate suggests that the New Brunswick healthcare giant has developed an unusual formula for making you wealthy if you get your name on the ownership of shares and never part with them.
V * = Intrinsic value EPS = Trailing twelve months earnings / share 8.5 = P / E base for a no - growth company g = Expected long term earnings growth rate 4.4 = Average yield of high - grade corporate bonds in 1962, when the formula was introduced Y = Current average yield on 20 year AAA corporate bonds
The yield is currently at 4.45 % based on the CAD 0.66 quarterly dividend payout.I have valued the shares using a dividend discount model analysis with a 10 % discount rate and an 7 % long - term growth rate.
Starting on December 31, 1954 (we need five years of data to compute the compound five - year earnings growth rate), $ 10,000 invested in the 50 stocks from the All Stocks universe with the highest five - year compound earnings - per - share growth rates grew to $ 1,287,685 by the end of 2003, a compound return of 10.42 percent (Table 12 - 1).
The projected 10 - year rate of return (calculated using the current price and the projected price in 10 years based on the sustainable growth rate, projected book value per share and earnings per share, and historical average price - earnings ratio) is greater than or equal to 15 %
In order to pass either screen, a company must rank in the top 25 % of the stock universe based on long - term earnings growth, have a three - year earnings per share growth rate that is equal to or exceeds its seven - year earnings growth rate, and have positive earnings for each of the last seven years.
Cumulatively, the organic dividend growth rate on those shares has been a solid 12.0 %.
All value stocks are then ranked based on six historical (and available at the time) criteria: market cap, stock liquidity (i.e., trading volume / shares), asset turnover (i.e., assets / revenues), total debt to equity, cash to assets and year - over-year EBIT annual growth rate, one variable at a time.
@JBentley — The cost of real estate (such as residential property, and the real estate used for retailing, restaurants, office space, and manufacturing) is already such a large fraction of the economy that the share of a region's economy that is spent on rent (or rent substitutes, such as the cost of home ownership) can not greatly exceed the region's economic growth rate for more than one or two business cycles.
When this method is applied on a share - by - share basis of a dividend stock, then it's called either the Dividend Discount Model or Method (generally), or the Gordon Growth Model (under expectations of a perpetual static growth Growth Model (under expectations of a perpetual static growth growth rate).
EPR's heavy reliance on debt and equity markets for growth capital means that should interest rates rise too high, and its share price remain too low, the REIT might have to start retaining more AFFO to fund growth internally.
These projections are analyzed in multiple ways, comparing year - on - year growth rates, market share, CAGRs, and absolute amounts in USD between the regions and segments, as well as the development of specific regions or segments in time.
TreeHugger readers have shared their own organic experiences in an instant survey... now the German Farmers» Association (Bauernverband) has published some hard and fast statistics on the situation in Germany, a country often perceived as a leader in the bio and organic fields.The growth rates make China's economy appear to be in slow motion: organic carrots took the lead with 50 % growth over last year.
The data predicted a compound annual growth rate of 4 % for the 2016 - 2021 period, with on - demand music services expected to double revenue and secure a 40 % share of the industry by 2021.
Windex Hearing Aid Company (Long Island City, NY) 1998 — 2005 Senior Marketing Coordinator / Sales • Built product awareness through varied marketing efforts including trade show events and advertising initiatives • Served as liaison to healthcare professionals and collaborated with the creative department and sales representatives • Achieved triple digit sales growth and 140 % increase in hearing healthcare market share • Recognized for accomplishments with rating of «outstanding» for seven consecutive years • Secured product placement on «Extreme Makeover» television show and acquired product spokesperson • Featured on Larry King and Wayne Brady television programs as a result of successful marketing initiatives • Designed and implemented continuing education programs for healthcare professionals boosting company reputation • Initiated use of Geographic Information System database to detect critical hearing healthcare and sales trends • Located areas of non-production leading to expansion of company revenues • Distributed new product mailings to over 3500 accounts building brand awareness and enhancing overall sales • Automated advertising program reducing processing time by 65 % while expanding program and sales
Non-shared and shared environments had no effect on the stability, initial status and growth rate in PA..
The top 25 markets were then ranked relative to one another based on each MSA's share of national population and employment growth relative to its size, change in single - family building permits, and the current unemployment rate (see the Methodology section for additional details).
Goldman Sachs, ahead of the data, upgraded its rating on the shares of several builders and said it expects growth in housing activity in a range of 20 percent to 30 percent for each of the next few years.
As more people «Like» their video tours of home listings or share them on Facebook, Twitter, LinkedIn, Pinterest, Google Plus, Tumblr, or Instagram, the potential growth rate of viewers is almost limitless.
a b c d e f g h i j k l m n o p q r s t u v w x y z